Novocuff is a medical device firm committed to improving pregnancy outcomes and lowering the risk of preterm birth.
Novocuff has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in July 2024.
Novocuff's investors include AXA Investment Managers, March of Dimes, Laerdal Million Lives Fund, RH Capital, Laborie Medical Technologies.
Novocuff is headquartered in Mountain View, United States.
Novocuff is a medical device firm committed to improving pregnancy outcomes and lowering the risk of preterm birth.
Novocuff is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Novocuff — Funding & Investors." VCBacked, July 17, 2024, https://www.vcbacked.co/company/novocuff. Accessed July 26, 2026.
VCBacked. (2024). Novocuff — Funding & Investors. Retrieved July 26, 2026, from https://www.vcbacked.co/company/novocuff
{{cite web |title=Novocuff — Funding & Investors |url=https://www.vcbacked.co/company/novocuff |website=VCBacked |access-date=July 26, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated